tiprankstipranks
Pure Bioscience (PURE)
:PURE
US Market

Pure Bioscience (PURE) Price & Analysis

Compare
42 Followers

PURE Stock Chart & Stats


---

Financials

Quarterly

Ownership Overview

40.91%0.72%58.37%
40.91%
Insiders
0.72% Other Institutional Investors
58.37% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

PURE FAQ

What was Pure Bioscience’s price range in the past 12 months?
Pure Bioscience lowest stock price was $0.04 and its highest was $0.16 in the past 12 months.
    What is Pure Bioscience’s market cap?
    Pure Bioscience’s market cap is $10.93M.
      When is Pure Bioscience’s upcoming earnings report date?
      Pure Bioscience’s upcoming earnings report date is Jun 12, 2025 which is in 70 days.
        How were Pure Bioscience’s earnings last quarter?
        Pure Bioscience released its earnings results on Mar 17, 2025. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.007.
          Is Pure Bioscience overvalued?
          According to Wall Street analysts Pure Bioscience’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Pure Bioscience pay dividends?
            Pure Bioscience does not currently pay dividends.
            What is Pure Bioscience’s EPS estimate?
            Pure Bioscience’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Pure Bioscience have?
            Pure Bioscience has 111,856,476 shares outstanding.
              What happened to Pure Bioscience’s price movement after its last earnings report?
              Pure Bioscience reported an EPS of -$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -14.286%.
                Which hedge fund is a major shareholder of Pure Bioscience?
                Currently, no hedge funds are holding shares in PURE
                ---

                Company Description

                Pure Bioscience

                PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Church & Dwight
                Clorox
                Ecolab
                RPM International
                Henkel AG
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis